Recent news on Ultravist

euro adhoc: Bayer Schering Pharma AG / Interim Announcement  -  May 9, 2007
Finanztreff,In the Diagnostic Imaging business unit, sales of Magnevist® rose, while those of Ultravist® fell markedly from the prior-year quarter.

UC San Diego Ranked Among World’s Top Universities as Biotech ...  Sep 21, 2006
...include: Erbitux® for the treatment of colorectal and head and neck cancers; Elmiron® for the treatment of interstitial cystitis; Ultravist® for ultrasound ... -New Age Media Concepts

Berlex recalls intravenous X-ray injection lot  Jul 20, 2006
Profile, Research) (SCHG.DE: Quote, Profile, Research) on Thursday recalled a single lot of its intravenous X-ray contrast agent, Ultravist Injection, because ... -Reuters



Berlex, Amerinet Extend and Enhance Agreement for Contrast Media  Jan 20, 2006
Ultravist(R) Joins Magnevist(R) as part of Amerinet's Portfolio of Contracted Contrast Agents WAYNE, NJ, Jan. 20 /PRNewswire/ -- Berlex ... - PR Newswire

Berlex, Amerinet Extend and Enhance Agreement for Contrast Media  Jan 20, 2006
In addition to Magnevist (gadopentetate dimeglumine) injection, the contract will allow Ultravist (iopromide) injection to be available to members of the ... - Biotech Intelligence

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional